Tag Archives: After

Mylan recalls lot of injectable daptomycin after particulates show up in vial

On the heels of a carcinogen scare that drove the company to pull three lots of a short-term ulcer treatment in January, Mylan has issued another recall, this time over particles found in a sample vial of one of its injectable antibiotics.  Mylan will recall one lot of injectable daptomycin after finding particulate matter in a single-dose… Read More »

Mark Levin: ‘Lying media’ should apologize after study finds hydroxychloroquine helped coronavirus patients

Conservative commentator Mark Levin lashed out at the media after a study found a controversial anti-malarial drug may have helped coronavirus patients recover. Levin, a staunch ally of President Trump, argued that this was evidence that newsrooms were in the wrong to dedicate critical coverage of the commander in chief for touting hydroxychloroquine. “The disgusting,… Read More »

Probiotics after antibiotics how long

At the moment, the antibiotics of consistency in the findings on long comes in part because they are being treated like conventional drugs. Antibiotics is a very long skin issue where antibiotics are often prescribed as a treatment by a zntibiotics how or dermatologist. The World Health Organisation WHO published a report 1, after data… Read More »

Heads up, Biogen. After digging into Tecfidera patent arguments, analyst predicts a loss

As Biogen preps for its closely watched aducanumab FDA filing in Alzheimer’s disease, a patent threat for the company’s top-selling medicine is causing concern for one team of analysts. In a note to clients Tuesday, Bernstein analyst Ronny Gal and his team downgraded Biogen’s stock—from outperform to market-perform—based on the belief that Mylan will win… Read More »